Ingood by Olga touts Sulfodyne for women’s health and PMS support
18 Jul 2025 | Ingood by Olga
Claire Boniface, the marketing and communications manager at Ingood by Olga, spoke with us about the company’s latest Sulfodyne real-life clinical study, which she said underscores its advantages over traditional premenstrual syndrome (PMS) supplements like magnesium and chasteberry. She discussed exciting potential new applications for Sulfodyne in women’s health beyond PMS, including endometriosis and mood disorders, highlighting the company’s mission to address the diverse unmet needs within the women’s health category.
Hello everybody, this is William Bradford Nichols, the editor for Nutrition Insight, and I am here live at Vita Foods Europe in Barcelona, Spain.
And today we are speaking with Claire Boniface, the marketing and communications manager at In Good by Olga.
How are you today, Claire?
Fine, and you?
We're excited to talk to you.
I've got some questions, and if it's OK, I'd like to just jump right in.
All right, Recently you guys did a real life study on sulfadyne with some pretty interesting results, impressive results for PMS symptoms.
Can you tell me how this study sort of strengthens your clinical positioning compared to traditional supplements like magnesium or chaseberry?
Yes, research has shown that chronic.
And also sed rates are involved in and sul is a broccoli to 5% of sulf with the highest concentration and with the highest durability available on the market.
Since sulfodyne is sort of standardized to that 5% active sulfur.
What you said is the highest in the market.
What stability and formulation challenges did you face in sort of achieving that standardization?
We had a huge challenge because you know on the market there are not many.
We are the only ones to offer the sulfuran in its active form.
It's a patented ingredient and the sulfur doesn't exist naturally in its active form.
It exists in its inactive form, a precursor which name is gluco.
It is converted thanks to an enzyme called mirosse and like many active compounds, the paraffin is a very sensitive and unstable molecule compound.
So the main challenge was to source sustainable and high quality broccoli seeds and next to extract a paraffan in its active form and to stabilize it.
It was a very huge challenge.
For us, and it took 20 years to develop it.
You've also highlighted the role of NRF2 activation and inflammation reduction for PMS.
Are you exploring additional applications for sulfodyne beyond for things like endometriosis, perimenopause, mood related disorders, and other things that go along with women's health?
Yes, absolutely, because sulfur and notably NO2 activation is gaining interest in managing many disorders in women's health.
And we really believe that activation can help.
So that's why we are investing in research and other applications for sulfur in women's health.
What formats are sort of most compatible with sulfodyne, and what does your formulation guidance look like for partners and customers?
Suldyne is suitable in 3 dri glinic forms in tablets.
Capsules and also in water for mixing.
And then finally, can you give us a little sneak peek into what's next for we continue to want to, we have to continue to develop sustainable ingredients to label and plant based because it remains central to our development strategic development and as we respond to consumer demands.
And also we want to continue to develop our research pipeline, especially in human health, with our ingredients sulfodine, and we also aim to continue to develop a long-term partner to bring this effective solution on the market.
That's great.
Thank you so much for talking with us today and sharing all your insights.
Great seeing you.
We look forward to hearing more from Ingo in the future.
